FDA Panel Favors Glaxo Epilepsy Drug

By: AP
By: AP

Federal health advisers say GlaxoSmithKline's epilepsy drug Potiga appears effective in controlling seizures.

An agency spokeswoman said the Food and Drug Administration's panel of neurologists voted unanimously that company studies showed the effectiveness of the drug. The panelists noted side effects, including the inability to urinate, but said they could be controlled by carefully monitoring patients.

British drug maker GlaxoSmithKline PLC has asked the FDA to approve the pill for epilepsy patients who continue experiencing seizures while taking other medications.

Epilepsy drugs already on the market include Johnson & Johnson's Topamax and Pfizer Inc.'s Neurontin.


KKTV firmly believes in freedom of speech for all and we are happy to provide this forum for the community to share opinions and facts. We ask that commenters keep it clean, keep it truthful, stay on topic and be responsible. Comments left here do not necessarily represent the viewpoint of KKTV 11 News.

If you believe that any of the comments on our site are inappropriate or offensive, please tell us by clicking “Report Abuse” and answering the questions that follow. We will review any reported comments promptly.

powered by Disqus
KKTV 520 E. Colorado Colorado Springs, CO 80903 Office: (719) 634-2844 Fax: (719) 632-0808 News Fax: (719) 634-3741
Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 100465614 - kktv.com/a?a=100465614
Gray Television, Inc.